UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis

Annals of the rheumatic diseases, 2007-07, Vol.66 (7), p.966-969

2007

Volltextzugriff (PDF)

Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres

Annals of the rheumatic diseases, 2011-10, Vol.70 (10), p.1788-1792

2011

Volltextzugriff (PDF)

Reduced non-switched memory B cell subsets cause imbalance in B cell repertoire in systemic sclerosis

Clinical and experimental rheumatology, 2016-09, Vol.34 Suppl 100 (5), p.30

2016

Volltextzugriff (PDF)

There is a need for new systemic sclerosis subset criteria. A content analytic approach

Scandinavian journal of rheumatology, 2018-01, Vol.47 (1), p.62-70

2018

Volltextzugriff (PDF)

Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards

Rheumatology (Oxford, England), 2015-01, Vol.54 (1), p.144-151

2015

Volltextzugriff (PDF)

Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud's disease

Journal of the European Academy of Dermatology and Venereology, 2004-01, Vol.18 (1), p.62-68

2004

Volltextzugriff (PDF)

Treat-to-target in systemic lupus erythematosus: where are we today?

Clinical and experimental rheumatology, 2012-07, Vol.30 (4 Suppl 73), p.S112

2012

Volltextzugriff (PDF)

Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: data from the EUSTAR database

Rheumatology (Oxford, England), 2012-10, Vol.51 (10), p.1832-1837

2012

Volltextzugriff (PDF)

FRI0261 Observational Study of Outcome in Patients with Early Diffuse Cutaneous Systemic Sclerosis Treated with Immunosuppressive Therapies (ESOS Study)

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.528-529

2016

Volltextzugriff (PDF)

OP0061 Update of Eular Recommendations for the Treatment of Systemic Sclerosis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.90-91

2015

Volltextzugriff (PDF)

European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research

Annals of the rheumatic diseases, 2009-05, Vol.68 (5), p.629-634

2009

Volltextzugriff (PDF)

AB0731 Investigation of Regulatory T Cells in Systemic Sclerosis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1143-1143

2015

Volltextzugriff (PDF)

AB0686 Switched Memory B Cell Expansion is Associated with Disease Severity in Systemic Sclerosis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1127-1127

2015

Volltextzugriff (PDF)

OP0031 Risk Factors for Malignancies Synchronous To The Onset of Systemic Sclerosis in Patients Positive for Anti- RNA Polymerase III Antibodies: A Eustar Multicentre Study

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.64-64

2016

Volltextzugriff (PDF)

European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria

Annals of the rheumatic diseases, 2003-09, Vol.62 (9), p.901-903

2003

Volltextzugriff (PDF)

The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy

Annals of the Rheumatic Diseases, 2009-09, Vol.68 (9), p.1377-1380

2009

Volltextzugriff (PDF)

FRI0370 Joint and tendon involvement predict severe disease progression in systemic sclerosis: a eustar prospective study

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A498-A498

2013

Volltextzugriff (PDF)

FRI0446 Severe Heart Disease in Systemic Sclerosis: Prevalence, Risk Factors and Current Treatment. A Eustar-Desscipher Study

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.589-589

2015

Volltextzugriff (PDF)

AB0442 Regional Patterns of Tocilizumab Use, Efficacy, and Safety in Patients with Rheumatoid Arthritis: Interim Results from a Multinational Observational Study

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1042-1043

2015

Volltextzugriff (PDF)

AB0727 There is a Need for New Systemic Sclerosis Subset Criteria. A Content Analytic Approach

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1141-1141

2015

Volltextzugriff (PDF)

Relationship between natural and infection‐induced antibodies in systemic autoimmune diseases (SAD): SLE, SSc and RA

Clinical and experimental immunology, 2021-01, Vol.203 (1), p.32-40

2021

Volltextzugriff (PDF)

Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis

Annals of the rheumatic diseases, 2008-02, Vol.67 (2), p.248-250

2008

Volltextzugriff (PDF)

Increased levels of amino terminal propeptide of type III procollagen are an unfavourable predictor of survival in systemic sclerosis

Clinical and experimental rheumatology, 2005-03, Vol.23 (2), p.165

2005

Volltextzugriff (PDF)

FRI0300 Baseline Characteristics and Pattern of TOCILIZUMAB Use in Patients with Rheumatoid Arthritis: Interim Results from the Multinational, Observational ACT-UP Study

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.493-494

2014

Volltextzugriff (PDF)

THU0257 Investigation of parameters of oral aperture in 131 patients with systemic sclerosis in a three-year single-centre prospective study

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.241-242

2013

Volltextzugriff (PDF)

1 – 25 von 307

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(265)
Mit Volltextzugriff
(216)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(173)
Humans
(159)
Life Sciences & Biomedicine
(151)
Female
(117)
Middle Aged
(106)
Male
(102)
Adult
(94)
Rheumatology
(84)
Biological And Medical Sciences
(64)
Medical Sciences
(62)
Aged
(54)
Systemic Sclerosis
(48)
Scleroderma
(42)
Scleroderma, Systemic - Complications
(36)
Scleroderma, Systemic - Immunology
(24)
Diseases Of The Osteoarticular System
(20)
Scleroderma, Systemic - Diagnosis
(20)
Severity Of Illness Index
(17)
Physical Sciences
(16)
Physics
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis

Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres

Reduced non-switched memory B cell subsets cause imbalance in B cell repertoire in systemic sclerosis

There is a need for new systemic sclerosis subset criteria. A content analytic approach

Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards

Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud's disease

Treat-to-target in systemic lupus erythematosus: where are we today?

Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: data from the EUSTAR database

FRI0261 Observational Study of Outcome in Patients with Early Diffuse Cutaneous Systemic Sclerosis Treated with Immunosuppressive Therapies (ESOS Study)

OP0061 Update of Eular Recommendations for the Treatment of Systemic Sclerosis

European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research

AB0731 Investigation of Regulatory T Cells in Systemic Sclerosis

AB0686 Switched Memory B Cell Expansion is Associated with Disease Severity in Systemic Sclerosis

OP0031 Risk Factors for Malignancies Synchronous To The Onset of Systemic Sclerosis in Patients Positive for Anti- RNA Polymerase III Antibodies: A Eustar Multicentre Study

European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria

The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy

FRI0370 Joint and tendon involvement predict severe disease progression in systemic sclerosis: a eustar prospective study

FRI0446 Severe Heart Disease in Systemic Sclerosis: Prevalence, Risk Factors and Current Treatment. A Eustar-Desscipher Study

AB0442 Regional Patterns of Tocilizumab Use, Efficacy, and Safety in Patients with Rheumatoid Arthritis: Interim Results from a Multinational Observational Study

AB0727 There is a Need for New Systemic Sclerosis Subset Criteria. A Content Analytic Approach

Relationship between natural and infection‐induced antibodies in systemic autoimmune diseases (SAD): SLE, SSc and RA

Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis

Increased levels of amino terminal propeptide of type III procollagen are an unfavourable predictor of survival in systemic sclerosis

FRI0300 Baseline Characteristics and Pattern of TOCILIZUMAB Use in Patients with Rheumatoid Arthritis: Interim Results from the Multinational, Observational ACT-UP Study

THU0257 Investigation of parameters of oral aperture in 131 patients with systemic sclerosis in a three-year single-centre prospective study

Suchergebnisse filtern